Defining the new normal of medical technology

COVID-19 has impacted every facet of life. From the outset of response, the medical and healthcare community has had to make the most significant shifts, including patient treatment protocols, virtual medicine implementation, and medical device development. And the pace at which changes occurred (and continue to occur) is exponential.

Consequently, some medical device companies have responded by modifying existing technologies to help patients and clinicians impacted by the pandemic. Others have found ways to meet virtually with doctors, regulators, and university tech transfer offices to address specific solutions.

In an effort to unite and inform the medical device community about the industry’s future in light of COVID-19, LaunchBio and the North Carolina Biotechnology Center are co-hosting a timely event as part of their Larger than Life Science series. This event features a panel of experienced CEOs discussing how they are successfully leading their teams during the pandemic crisis now and anticipating what can be expected during the eventual easing of restrictions across the country.

Rita King, our CEO and Senior Consultant, was selected to serve as a panelist for this discussion, which will include insights into the impact of telemedicine on the industry, and what hospitals, insurers, and investors are prioritizing for innovation and patient care.

During the COVID-19 crisis, Rita and MethodSense have led numerous companies and their medical device products through the FDA Emergency Use Authorization (EUA) process. Many of these clients are new to the medical device industry and must become medical device companies almost overnight. Now, most of these innovative organizations are looking beyond the EUA to become traditional medical device companies.

To further support those in our medical device community wanting to submit device authorization requests at this time under the emergency Guidance, Rita also led the Methodsense effort to launch the EUA Resource Site. This resource combines our 20 years of compliance proficiency with numerous experts in the medical device field to answer your questions about the EUA Authorization process.

Want to join this Larger Than Life Science event?
Wednesday, May 13, 2020
4:00 PM – 5:00 PM EDT via Zoom.
Register for FREE at LARGER THAN LIFE SCIENCE: Advancing Technologies

This website uses cookies and asks your personal data to enhance your browsing experience. We are committed to protecting your privacy and ensuring your data is handled in compliance with the General Data Protection Regulation (GDPR).